Tony Succar, PhD, MScMed(OphthSc), is passionate about applying his regulatory, clinical and translational research experience to teaching regulatory science for pharmaceuticals, biologics, medical devices, and combination products, as well as clinical trial optimization to the next generation of regulatory specialists and clinical trialists. Dr. Succar earned his Master of Science in Medicine (Ophthalmic Science) from The University of Sydney School of Medicine, Australia, in the development of a bionic eye for people living with blindness and severe vision impairment. His research involved designing a first-in-human clinical trial investigating bioelectrical stimulation parameters: frequency, pulse duration and amplitude of currents within the visual system, for eliciting the perception of phosphenes – a form of artificial vision. Blind participants who perceived phosphenes as a result of the bioelectric stimulation were ideal candidates for the implantation of the bionic eye. He was subsequently awarded The University of Sydney Postgraduate Scholarship in Vision and Eye Health Research, where he completed his PhD in the development of a Virtual Ophthalmology Clinic (VOC) on which medical students can sharpen their clinical reasoning skills by formulating a diagnosis and treatment plan on virtual patients with simulated eye conditions. A randomized controlled trial (RCT) was designed and conducted to evaluate its educational effectiveness versus traditional instruction, and he was honored to receive the Best Oral Presentation in Educational Research at the Annual Nepean Scientific Day for this research, as well as receiving the Higher Education Research and Development Society of Australia (HERDSA) Conference Grant. At the University of Sydney, Dr. Succar served as a Clinical Associate Lecturer and was later promoted to Clinical Senior Lecturer. Driven by his passion to help people with incurable blindness, he travelled to the United States to pursue his clinical and translational research endeavors with the invention of a virtual vision rehabilitation program for restoring functional 3D vision for people living with age-related macular degeneration and central vision loss. This software based medical device resulted in his first patent awarded by the United States Patent and Trademark Office (USPTO). Following this, he was appointed as a Postdoctoral Scholar-Research Associate at the University of Southern California, Keck School of Medicine of USC, where he investigated structure-function correlations of retinal diseases and pre-screened potential candidates for a novel retinal stem cell therapy clinical trial. He was recruited by Massachusetts Eye and Ear, Harvard Medical School, as the Clinical Research Project Manager, involved in conducting multiple national and international, industry and investigator initiated clinical trials significantly greater than minimal risk. Dr. Succar is a mentor in the Harvard Ophthalmology URM Mentorship Program. He recently served as Principal Instructor in the Regulatory Affairs program at Northeastern University, where he received the 2024 CPS Excellence in Teaching Award Nomination. He has disseminated his research widely at national and international conferences and has been published in peer-reviewed journals such as Medical Teacher, Journal of Academic Ophthalmology, Ophthalmology, Eye, Investigative Ophthalmology and Visual Science, Asia Pacific Journal of Ophthalmology, and Survey of Ophthalmology, as well authoring chapters in academic textbooks: (1) Digital Teaching, Learning and Assessment: The Way Forward, (2) In Their Own Words: What Scholars and Teachers Want You to Know About Why and How to Apply the Science of Learning in Your Academic Setting, and (3) Strategies for Fostering Inclusive Classrooms in Higher Education: International Perspectives on Equity and Inclusion. Dr. Succar was a recent recipient of the Best of Journal of Academic Ophthalmology (JAO), awarded to the best 3 research articles published each year, and was invited to receive this award and present his research at the Association of University Professors of Ophthalmology (AUPO) Conference in San Diego, 2023.